-
Data Center Market in China in Internet Services & Infrastructure Industry | Post COVID-19 Analysis | Technavio
prnewswire
July 02, 2021
The internet services and infrastructure industry is expected to have a mixed impact due to the spread of the COVID-19 pandemic.
-
Global Syringes Market (2021 to 2026) - Featuring Nipro, Schott and Smiths Medical Among Others
prnewswire
July 02, 2021
The "Syringes: Technologies and Global Markets: 2021-2026" report has been added to ResearchAndMarkets.com's offering.
-
Women's Cancer Screenings Plummeted During Pandemic
drugs
July 01, 2021
Breast and cervical cancer screenings dropped sharply among low-income minority women during the COVID-19 pandemic, the U.S. Centers for Disease Control and Prevention says.
-
Most Americans Who Wanted COVID-19 Vaccine Have Already Gotten One
drugs
July 01, 2021
In another sign that COVID-19 vaccination rates have plateaued in America, a new poll shows that most adults who wanted a COVID-19 vaccine have already gotten one.
-
16.8 Million Undiagnosed COVID-19 Cases in First Six Months in U.S.
drugs
July 01, 2021
In the first six months of the COVID-19 pandemic in the United States, the overall weighted undiagnosed seropositivity estimate was 4.6 percent, according to a study published in the June 22 issue of Science Translational Medicine.
-
Drop Seen in Physician Work Hours During COVID-19 Pandemic
drugs
July 01, 2021
Physicians' working hours and full-time status declined significantly during the COVID-19 pandemic, according to a study published online June 23 in JAMA Network Open.
-
Brazil's Anvisa suspends Covaxin shot's emergency use application
firstwordpharma
July 01, 2021
Brazil's health regulator has suspended Covaxin's emergency-use application, which was filed by an intermediary on behalf of the COVID-19 vaccine's developer Bharat Biotech, as reported in This is Money.
-
Letting children catch Covid may be safer than giving them vaccine, say experts
firstwordpharma
July 01, 2021
A member of the UK's Joint Committee on Vaccination and Immunisation (JCVI) says allowing children to catch COVID-19 may be better than exposing them to the "risk" of vaccines, reported The Telegraph.
-
Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine
firstwordpharma
July 01, 2021
Novavax today announced the publication of results from the final analysis of a pivotal Phase 3 clinical trial of its COVID-19 vaccine candidate conducted in the United Kingdom in the New England Journal of Medicine (NEJM).
-
Results of Biophytis SARA-INT Phase 2 Trial with Sarconeos (BIO101) in Sarcopenia will be Released by August 2021
firstwordpharma
July 01, 2021
Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), ("Biophytis" or the "company"),a clinical-stage biotechnology company today announces topline results for SARA-INT phase 2 study will be released in August 2021.